SCHEMBL10162406

SCHEMBL10162406

CC(=O)c1cn2cccnc2n1

nearest known ligand 0.64

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 10/20 0.64
KDM4E B2RXH2 10/20 0.64
HPGD P15428 7/20 0.64
RAB9A P51151 9/20 0.51
NPC1 O15118 7/20 0.51
GAA P10253 6/20 0.51
GLA P06280 5/20 0.51
HSD17B10 Q99714 5/20 0.51
SMN1; SMN2 Q16637 3/20 0.51
CYP1A2 P05177 2/20 0.51
RXFP1 Q9HBX9 1/20 0.48
KMT2A Q03164 4/20 0.46
MEN1 O00255 3/20 0.46
POLB P06746 1/20 0.43
TP53 P04637 3/20 0.43
MAPT P10636 1/20 0.43
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
RCE1 Q9Y256 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL570407 0.84 ALDH1A1 (0.61) ALDH1A1KDM4EHPGDRAB9ANPC1
SCHEMBL2335762 0.83 ALDH1A1 (0.60) ALDH1A1KDM4EHPGDRAB9ANPC1
SCHEMBL1901476 0.83 ALDH1A1 (0.60) ALDH1A1KDM4EHPGDRAB9ANPC1
SCHEMBL10130703 0.82 KDM4E (0.59) ALDH1A1KDM4EHPGDRAB9ANPC1
SCHEMBL18754841 0.80 KDM4E (0.57) ALDH1A1KDM4EHPGDRAB9ANPC1
SCHEMBL1407731 0.79 KDM4E (1.00) ALDH1A1KDM4EHPGDRAB9ANPC1
SCHEMBL12200399 0.78 KDM4E (0.55) ALDH1A1KDM4EHPGDRAB9ANPC1
SCHEMBL7305755 0.75 KDM4E (0.52) ALDH1A1KDM4EHPGDRAB9ANPC1
SCHEMBL10205883 0.73 KDM4E (0.50) ALDH1A1KDM4EHPGDRAB9ANPC1
SCHEMBL14730822 0.72 CD38 (0.49) ALDH1A1KDM4EHPGDRAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4061815-A1 PYRIMIDONE DERIVATIVES CONTAINING TWO FUSED BICYCLIC RINGS BASF SE (DE) 2022-09-28 EP disclosed
WO-2021099240-A1 PYRIMIDONE DERIVATIVES CONTAINING TWO FUSED BICYCLIC RINGS BASF SE (DE) 2021-05-27 WO disclosed
US-8906913-B2 Azabicyclohexanes PANACEA BIOTEC LIMITED (IN) 2014-12-09 US disclosed
US-20120165320-A1 NOVEL AZABICYCLOHEXANES PANACEA BIOTEC LTD. (IN) 2012-06-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120165320-A1 NOVEL AZABICYCLOHEXANES CYP3A43, UGT1A1, CYP3A4 ALDH1A1 295/4885KDM4E 2799/4885HPGD 443/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.